Micro-x Ltd. · ASX:MX1

Micro-x — Evans and Partners Investor Conference 2021

19 slides from Micro-x's conference presentation, Mar 24, 2021

  1. Slide 1: Micro-X to present at Evans and Partners Investor Conference

    Micro-X Limited, ABN 21 153 273 735 EVANS AND PARTNERS INVESTOR CONFERENCE Micro-X to present at 4.20 pm AEDT on 24 March 2021 For personal use only Adelaide, Australia, 24 March 2021: Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X or the Company), a leader in cold cathode x-ray technolog

  2. Slide 2: Evans & Partners Investor Conference

    For personal use only ACN 153 273 735 ASX: MX1 Evans & Partners Investor Conference 24 March 2021 Peter Rowland Managing Director & CEO A new era in X-ray imaging

  3. Slide 3: Important Notice Disclaimer

    I M P O R TA N T N O T I C E DISCLAIMER SCOPE & LIMITATIONS This Presentation has been prepared by Micro-X Limited (Micro-X or the Company) (ASX.MX1). The Presentation is a summary only and does not For personal use only contain all the information about the Company’s assets and liabilities, financi

  4. Slide 4: Overview: Next generation x-ray for global health and security markets

    OVERVIEW NEXT GENERATION X-RAY FOR GLOBAL HEALTH AND SECURITY MARKETS For personal use only Platform technology in cold cathode x-ray • X-ray products with significant reduction in size, weight and power • Patented technology – platform for health and new security applications • First to market with

  5. Slide 5: Our Strategy: Monetise our first mover advantage

    O U R S T R AT E G Y MONETISE OUR ‘FIRST MOVER’ ADVANTAGE For personal use only OUR GOAL Successful first movers in breakthrough technology move Four global production lines: Commercialise high in the quickly: - common technology platforms value chain to maximise early commercial domination revenue

  6. Slide 6: Sequenced product rollout across four production lines

    O IVGENRI VF I E S CWA NOT FMMAIRCKREOT- S X ACROSS FOUR PRODUCTION LINES Next generation X-ray for global health and security markets SEQUENCED PRODUCT ROLLOUT AS CNT MANUFACTURING EXPANDS For personal use only MOBILE BEDSIDE DR IED X-RAY CAMERA AIRPORT CHECKPOINT BRAIN CT SCANNER 2018 2022* 2023*

  7. Slide 7: Mobile DR: Nano mobile x-ray for healthcare

    M O B I L E D R : N A N O M O B I L E X - R AY F O R H E A L T H C A R E APPROVED FOR SALE IN 40 COUNTRIES – significant COVID-19 sales demand For personal use only $4.2m Bedside imaging – hospitals & temporary facilities Small & portable – 95kg compared to 350-600kg Purchase orders in Approvals – F

  8. Slide 8: Mobile DR: Rover for military and remote users

    M O B I L E D R : R O V E R F O R M I L I TA RY & R E M O T E U S E R S FIRST CONTRACT FOR ADF - STRONG MILITARY INTEREST & UNMET NEED For personal use only Rover is an adapted version of the Nano for military use • Deployed medical facilities treat injured military personnel $1.4m Sales via WHO in

  9. Slide 9: IED Imaging Camera

    IED IMAGING CAMERA BACKSCATTER X-RAY ASSESSMENT OF IEDS VIA ROBOT For personal use only $1.8b X-Ray camera takes images without separate detector– one sided viewing Addressable market Bomb disposal technicians face life threatening situation when placing conventional X-ray detector behind target Aus

  10. Slide 10: Airport Self-Service Checkpoint

    AIRPORT SELF-SERVICE CHECKPOINT US DEPT OF HOMELAND SECURITY - TWO CONTRACTS TOTALLING US$4M For personal use only • A blend of backscatter and transmission X-ray to provide three US$24.0b dimensional imaging of carry on luggage • Integrated body scanner and passport reader Addressable market • Base

  11. Slide 11: Brain Tomography for Stroke Diagnosis

    BRAIN TOMOGRAPHY FOR STROKE DIAGNOSIS MOBILE POINT-OF-CARE DIAGNOSIS - $8M MRFF FUNDING AWARDED For personal use only US$5.0b Addressable market • New medical imaging technology for enhanced diagnosis of strokes in a mobile setting - road or air ambulance • Curved detector will be the first of its k

  12. Slide 12: Established Capability: Manufacturing Operations

    E S TA B L I S H E D C A PA B I L I T Y: M A N U FA C T U R I N G O P E R AT I O N S WORLD-CLASS MANUFACTURING - EFFICIENCIES FROM AUTO INDUSTRY For personal use only 2 Mobile DR • State of the art manufacturing facility spanning 2,000m2 • Adelaide’s Tonsley Innovation District • ISO 13485 certified

  13. Slide 13: Established Capability: Engineering Design

    E S TA B L I S H E D C A PA B I L I T Y: E N G I N E E R I N G D E S I G N WORLD-CLASS CAPABILITY IN MULTI-DISCIPLINARY SYSTEMS DESIGN For personal use only • Customer-led design methodology; proven fast track development process • 27 engineers and scientists covering: Mechanical & Materials; Electr

  14. Slide 14: Platform Technologies: Image Processing

    P L AT F O R M T E C H N O L O G I E S : I M A G E P R O C E S S I N G IMAGE RECONSTRUCTION & PROCESSING For personal use only • Proprietary imaging software leveraging unique properties of CNT x-ray images • Airport security combines conventional Backscatter Image Reconstruction and Display x-ray 3

  15. Slide 15: Experienced Leadership

    EXPERIENCED LEADERSHIP TECHNICAL AND COMMERCIAL EXPERTISE TO SUPPORT OUR OBJECTIVES For personal use only Peter Rowland David Knox Patrick O’Brien Yasmin King Dr Alexander Gosling, AM Jim McDowell Managing Director & CEO Non-Executive Chairman Non-Executive Director Non-Executive Director Non-Execut

  16. Slide 16: Corporate Snapshot

    C O R P O R AT E S N A P S H O T GROWTH STAGE COMPANY WITH INSTITUTIONAL SUPPORT For personal use only MX1 - Share Trading ( 1 January 2020 to 17 March 2021) Millions $0.45 25.0 $0.40 20.0 $0.35 $0.30 15.0 $0.25 $0.20 10.0 $0.15 $0.10 5.0 $0.05 $0.00 0.0 02 Jan 16 Jan 30 Jan 13 Feb 27 Feb 12 Mar 26

  17. Slide 17: Expected Milestones & News Flow

    OVERVIEW OF MICRO-X EXPECTED MILESTONES & NEWS FLOW Next generation X-ray for global health and security markets INITIATIVES TO DELIVER COMMERCIAL OUTCOMES FOR ALL STAKEHOLDERS For personal use only First IED Camera Demonstration Ongoing Nano and Rover Sales Grow Nano and Rover paths to market Brain

  18. Slide 18: Conclusion

    CONCLUSION UNLOCKING VALUE FROM REVOLUTIONARY COLD CATHODE TECHNOLOGY For personal use only • Own the proven technical edge • Products with revenues in 26 counties • Multiple product lines in design • Massive addressable markets • Customer pull – not technology push • Demonstrated design & manufactu

  19. Slide 19: Thank You

    For personal use only ACN 153 273 735 ASX: MX1 Thank You Peter Rowland Managing Director & CEO A new era in X-ray imaging

Micro-X — Evans and Partners Investor Conference 2021 on 6ix